When a federally sponsored expert panel recommended that men not routinely undergo PSA testing for prostate cancer risk, it touched off a firestorm of controversy that continues today. Media reports presented conflicting expert opinions on the pros and cons of PSA screening for cancer. In such uncertain times, it behooves all men to learn as much as they can about the risks and benefits of PSA testing and make a deeply informed decision that could have serious health consequences—both good and bad.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.